Discover how Preservative Freedom Coalition member Dr. Jacob Lang, O.D. consistently delivers exceptional care to his patients. Press Release: https://lnkd.in/e9jgmpbt
Thea Pharma US
制药业
Waltham，Massachusetts 9,396 位关注者
We continue to lead the worldwide preservative-free movement in eye care.
关于我们
Established in Lexington, Massachusetts in 2019, Thea Pharma, Inc., is the United States subsidiary of Théa. Its product offering is comprised of a portfolio of seven leading eye-care products that are regulated or approved by the U.S. Food and Drug Administration (FDA), including Zioptan?, AcellFX?, Cosopt?, Cosopt? PF, Azasite?, Akten?, and Betimol?, iVIZIA dry-eye drops and eyelid hygiene products, and now IYUZEH?. By focusing our passion and expertise within the U.S. market, Thea Pharma's goal is to deliver uncompromising care that allows all stakeholders to envision the future of ophthalmic treatment with eyes wide open. To learn more about Thea Pharma, Inc., visit https://theapharmainc.com.
- 网站
-
https://www.theapharmainc.com
Thea Pharma US的外部链接
- 所属行业
- 制药业
- 规模
- 51-200 人
- 总部
- Waltham，Massachusetts
- 类型
- 私人持股
- 创立
- 2019
- 领域
- Ophthalmology、Optometry、Eye Health、Pharmaceuticals和OTC
地点
-
主要
获取路线
303 Wyman St
Suite 205
US，Massachusetts，Waltham，02451
Thea Pharma US员工
动态
-
Based on a survey of 558 glaucoma patients in the US, only 1 in 5 patients are satisfied with their current eye treatments. Learn more about opportunities to improve the patient experience. https://lnkd.in/e9jgmpbt #PreservativeFreedom #EyeHealth #Optometry #Ophthalmology #GlaucomaAwarenessWeek #EyeDrops #Glaucoma
-
-
Based on a survey of 558 glaucoma patients in the US, more than 60% of US glaucoma patients are concerned about the complications that could arise from the toxicity of their eye drops. It’s time to make preservative-free part of the conversation. Press Release: https://lnkd.in/e9jgmpbt #PreservativeFreedom #EyeHealth #Optometry #Ophthalmology #GlaucomaAwarenessWeek #EyeDrops #Glaucoma
-
-
Around?80 million people worldwide?are suffering from glaucoma.?Glaucoma?is?one of?the leading causes of irreversible blindness?worldwide1;2. Glaucoma is a degenerative eye disease characterized by progressive and irreversible destruction of the optic nerve. It is often described as a “silent thief of sight” because most people with glaucoma have no symptoms. Today, there are several effective options for managing glaucoma.?Ask your doctor about the alternatives available such as preservative-free and phosphate-free eyedrops or low-dosage treatments?;?. At Thea, we believe our goal of delivering uncompromising care begins with preservative-free solutions. We are committed to helping eyecare professionals make informed decisions that result in better ocular health for patients. #Thea #LetsOpenOurEyes #NeverStopLearning #GlaucomaAwareness
-
Around?80 million people worldwide?are suffering from glaucoma.?Glaucoma?is?one of?the leading causes of irreversible blindness?worldwide1;2. Glaucoma is a degenerative eye disease characterized by progressive and irreversible destruction of the optic nerve. It is often described as a “silent thief of sight” because most people with glaucoma have no symptoms. Today, there are several effective options for managing glaucoma.?Ask your doctor about the alternatives available such as preservative-free and phosphate-free eyedrops or low-dosage treatments?;?. At Thea, we believe our goal of delivering uncompromising care begins with preservative-free solutions. We are committed to helping eyecare professionals make informed decisions that result in better ocular health for patients. #Thea #LetsOpenOurEyes #NeverStopLearning #GlaucomaAwareness
-
Patients reported improved satisfaction and tolerability after switching to preservative-free latanoprost. Discover more at https://lnkd.in/dKxAgHSi. In the US clinical trial, the mean IOP baseline was 18.8 mmHg for IYUZEH? (latanoprost ophthalmic solution) 0.005% (n=165) and 19.2 mmHg for XALATAN? (n=169) compared with 24.1 mmHg for IYUZEH (n=189) and 24.0 mmHg for XALATAN (n=164) in the European clinical trial, accounting for the smaller, yet still clinically meaningful IOP-lowering effect.1-4 XALATAN is a registered trademark of Pfizer PFE Holdings 4 LLC, a Viatris Company. Please see the IYUZEH full Prescribing Information at iyuzeh.com/PI and Important Safety Information at iyuzeh.com/#isi. #thea #eyehealth
-
March is Workplace Eye Wellness Month! Each year, nearly 25,000 Americans visit the ER due to workplace eye injuries. The American Academy of Ophthalmology reminds us to wear certified eye protection to stay safe. #EyeSafety #WorkplaceHealth #thea
-
-
?? Inherited retinal diseases or IRDs have a profound impact on individuals and families around the world. On Rare Disease Day, Théa through Sepul Bio, its innovative business unit, aims at supporting this community affected by IRDs such as LCA10 and Usher2a, through our two dedicated research programs. Discover more about Sepul Bio, link in comment ?? #SepulBio #Théa #RareDiseaseDay #LetsOpenOurEyes"
[Rare Disease Day ??] Today, Sepul Bio reaffirms its commitment bring treatments to those affected by rare eye diseases such as LCA10 and Usher2a. ???Sepul Bio is dedicated to innovation and advancing therapies in the hope of providing treatment options for rare genetic eye diseases. ????? ???Join us in our mission to work collaboratively with the community be it, individuals, families, and healthcare professionals in the pursuit of new treatment options.?????? To find out more about Sepul Bio, link in comment ???? #SepulBio #RareDiseaseDay #Innovation #CommunityCare Laboratoires Théa
-
-
Thea Pharma US is proud to sponsor Black Eyecare Perspective, an organization founded by Drs. Adam Ramsey and Darryl Glover to foster lifelong connections between Black eyecare professionals and the eyecare industry.
-
-
Thea Pharma US looks forward to engaging all American Glaucoma Society attendees and members at booth # 49.
-